Affi-BAMS: A Robust Targeted Proteomics Microarray Platform to Measure Histone Post-Translational Modifications

Ghaith M Hamza1,2, Eric Miele1, Don M Wojchowski2

  • 1Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Boston, MA 02451, USA.

Summary

The Affi-BAMS platform offers a sensitive and precise method for quantifying histone post-translational modifications (PTMs). This technology enables detailed analysis of epigenetic marks crucial for gene expression and chromatin structure.